Encompass Health Corporation (EHC) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $221.60M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $588.40M; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $221.60M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $221.60M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $588.40M | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $588.40M |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 4.00B USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | 221.60M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | |
| Deferred revenue due within one year | (m) | |
| Deferred revenue due after one year | (m) | |
| Reported other obligations due within one year | 588.40M USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 212.20M USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $588.40M
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $208.30M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $221.60M | (m) | $588.40M | (m) | $4.00B | (m) | (m) | (m) | $212.20M | (m) |
| 2026-03-31 | (m) | $204.00M | (m) | $603.00M | (m) | $3.95B | (m) | (m) | (m) | $214.50M | (m) |
| 2025-12-31 | (m) | $178.20M | (m) | $289.60M | (m) | $3.81B | (m) | (m) | (m) | $53.80M | (m) |
| 2025-09-30 | (m) | $138.40M | (m) | $558.70M | (m) | $3.68B | (m) | (m) | (m) | $213.20M | (m) |
| 2025-06-30 | (m) | $174.50M | (m) | $525.90M | (m) | $3.70B | (m) | (m) | (m) | $200.80M | (m) |
| 2025-03-31 | (m) | $159.10M | (m) | $531.50M | (m) | $3.70B | (m) | (m) | (m) | $196.30M | (m) |
| 2024-12-31 | (m) | $171.00M | (m) | $238.60M | (m) | $3.69B | (m) | (m) | (m) | $51.80M | (m) |
| 2024-09-30 | (m) | $170.30M | (m) | $467.60M | (m) | $3.73B | (m) | (m) | (m) | $198.30M | (m) |
| 2024-06-30 | (m) | $164.20M | (m) | $471.20M | (m) | $3.86B | (m) | (m) | (m) | $186.90M | (m) |
| 2024-03-31 | (m) | $166.10M | (m) | $463.20M | (m) | $3.83B | (m) | (m) | (m) | $185.80M | (m) |
| 2023-12-31 | (m) | $170.00M | (m) | $187.40M | (m) | $3.81B | (m) | (m) | (m) | $46.10M | (m) |
| 2023-09-30 | (m) | $165.40M | (m) | $425.00M | (m) | $3.78B | (m) | (m) | (m) | $178.90M | (m) |
| 2023-06-30 | (m) | $155.80M | (m) | $416.20M | (m) | $3.80B | (m) | (m) | (m) | $175.80M | (m) |
| 2023-03-31 | (m) | $141.10M | (m) | $366.90M | (m) | $3.78B | (m) | (m) | (m) | $183.30M | (m) |
| 2022-12-31 | (m) | $132.90M | (m) | $181.00M | (m) | $3.77B | (m) | (m) | (m) | $45.30M | (m) |
| 2022-09-30 | (m) | $134.10M | (m) | $421.60M | (m) | $3.73B | (m) | (m) | (m) | $174.00M | (m) |
| 2022-06-30 | (m) | $138.30M | (m) | $611.20M | (m) | $4.54B | (m) | (m) | (m) | $177.00M | (m) |
| 2022-03-31 | (m) | $147.30M | (m) | $526.00M | (m) | $4.45B | (m) | (m) | (m) | $178.60M | (m) |
| 2021-12-31 | (m) | $137.60M | (m) | $219.70M | (m) | $4.47B | (m) | (m) | (m) | $49.40M | (m) |
| 2021-09-30 | (m) | $149.40M | (m) | $537.90M | (m) | $4.43B | (m) | (m) | (m) | $223.50M | (m) |
| 2021-06-30 | (m) | $145.10M | (m) | $550.60M | (m) | $4.40B | (m) | (m) | (m) | $219.10M | (m) |
| 2021-03-31 | (m) | $122.80M | (m) | $508.00M | (m) | $4.47B | (m) | (m) | (m) | $220.50M | (m) |
| 2020-12-31 | (m) | $115.00M | (m) | $218.30M | (m) | $4.44B | (m) | (m) | (m) | $93.80M | (m) |
| 2020-09-30 | (m) | $119.60M | (m) | $478.80M | (m) | $4.68B | (m) | (m) | (m) | $230.00M | (m) |
| 2020-06-30 | (m) | $93.10M | (m) | $492.20M | (m) | $4.64B | (m) | (m) | (m) | $191.70M | (m) |
| 2020-03-31 | (m) | $98.00M | (m) | $407.20M | (m) | $4.31B | (m) | (m) | (m) | $163.30M | (m) |
| 2019-12-31 | (m) | $94.60M | (m) | $303.80M | (m) | $4.15B | (m) | (m) | (m) | $42.70M | (m) |
| 2019-09-30 | (m) | $101.40M | (m) | $525.10M | (m) | $4.51B | (m) | (m) | (m) | $161.60M | (m) |
| 2019-06-30 | (m) | $95.60M | (m) | $574.00M | (m) | $3.88B | (m) | (m) | (m) | $157.20M | (m) |
| 2019-03-31 | (m) | $94.70M | (m) | $587.90M | (m) | $3.69B | (m) | (m) | (m) | $159.30M | (m) |
| 2018-12-31 | (m) | $90.00M | (m) | $333.90M | (m) | $3.36B | (m) | (m) | (m) | $85.60M | (m) |
| 2018-09-30 | (m) | $86.00M | (m) | $486.50M | (m) | $3.31B | (m) | (m) | (m) | $198.20M | (m) |
| 2018-06-30 | (m) | $85.60M | (m) | $452.30M | (m) | $3.36B | (m) | (m) | (m) | $189.80M | (m) |
| 2018-03-31 | (m) | $83.10M | (m) | $456.20M | (m) | $3.30B | (m) | (m) | (m) | $183.80M | (m) |
| 2017-12-31 | (m) | $78.40M | (m) | $210.00M | (m) | $3.25B | (m) | (m) | (m) | $75.20M | (m) |
| 2017-09-30 | (m) | $81.80M | (m) | $398.30M | (m) | $3.29B | (m) | (m) | (m) | $186.40M | (m) |
| 2017-06-30 | (m) | $77.50M | (m) | $377.50M | (m) | $3.30B | (m) | (m) | (m) | $182.60M | (m) |
| 2017-03-31 | (m) | $68.90M | (m) | $380.50M | (m) | $3.57B | (m) | (m) | (m) | $168.50M | (m) |
| 2016-12-31 | (m) | $68.30M | (m) | $197.10M | (m) | $3.61B | (m) | (m) | (m) | $49.60M | (m) |
| 2016-09-30 | (m) | $67.50M | (m) | $371.70M | (m) | $3.61B | (m) | (m) | (m) | $158.10M | (m) |
| 2016-06-30 | (m) | $67.10M | (m) | $355.50M | (m) | $3.66B | (m) | (m) | (m) | $154.10M | (m) |
| 2016-03-31 | (m) | $62.70M | (m) | $364.50M | (m) | $3.69B | (m) | (m) | (m) | $144.80M | (m) |
| 2015-12-31 | (m) | $61.60M | (m) | $172.10M | (m) | $3.71B | (m) | (m) | (m) | $43.00M | (m) |
| 2015-09-30 | (m) | $65.60M | (m) | $314.40M | (m) | $3.35B | (m) | (m) | (m) | $140.70M | (m) |
| 2015-06-30 | (m) | $60.00M | (m) | $283.20M | (m) | $2.61B | (m) | (m) | (m) | $137.30M | (m) |
| 2015-03-31 | (m) | $55.10M | (m) | $292.70M | (m) | $2.76B | (m) | (m) | (m) | $139.50M | (m) |
| 2014-12-31 | (m) | $53.40M | (m) | $145.60M | (m) | $2.61B | (m) | (m) | (m) | $37.60M | (m) |
| 2014-09-30 | (m) | $54.80M | (m) | $251.40M | (m) | $2.10B | (m) | (m) | (m) | $139.70M | (m) |
| 2014-06-30 | (m) | $55.70M | (m) | $243.60M | (m) | $1.92B | (m) | (m) | (m) | $141.10M | (m) |
| 2014-03-31 | (m) | $48.50M | (m) | $253.50M | (m) | $1.95B | (m) | (m) | (m) | $145.60M | (m) |
| 2013-12-31 | (m) | $61.90M | (m) | $122.80M | (m) | $1.96B | (m) | (m) | (m) | $44.00M | (m) |
| 2013-09-30 | (m) | $54.20M | (m) | $257.60M | (m) | $1.76B | (m) | (m) | (m) | $140.40M | (m) |
| 2013-06-30 | (m) | $57.30M | (m) | $254.30M | (m) | $1.76B | (m) | (m) | (m) | $131.40M | (m) |
| 2013-03-31 | (m) | $61.20M | (m) | $255.80M | (m) | $1.81B | (m) | (m) | (m) | $130.50M | (m) |
| 2012-12-31 | (m) | $45.30M | (m) | $130.40M | (m) | $1.68B | (m) | (m) | (m) | $30.20M | (m) |
| 2012-09-30 | (m) | $51.90M | (m) | $325.90M | (m) | $1.76B | (m) | (m) | (m) | $137.90M | (m) |
| 2012-06-30 | (m) | $59.60M | (m) | $265.00M | (m) | $1.68B | (m) | (m) | (m) | $135.80M | (m) |
| 2012-03-31 | (m) | $53.40M | (m) | $261.30M | (m) | $1.70B | (m) | (m) | (m) | $135.40M | (m) |
| 2011-12-31 | (m) | $45.40M | (m) | $134.10M | (m) | $1.68B | (m) | (m) | (m) | $30.40M | (m) |
| 2011-09-30 | (m) | $45.40M | (m) | $242.70M | (m) | $1.73B | (m) | (m) | (m) | $135.00M | (m) |
| 2011-06-30 | (m) | $45.40M | (m) | $273.70M | (m) | $1.89B | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | $50.80M | (m) | $287.10M | (m) | $2.02B | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $48.90M | (m) | $144.60M | (m) | $1.99B | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | $49.30M | (m) | $324.50M | (m) | $2.19B | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | $47.30M | (m) | $322.60M | (m) | $2.19B | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $50.20M | (m) | $319.50M | (m) | $2.19B | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |